InvestorsHub Logo
Followers 35
Posts 6308
Boards Moderated 0
Alias Born 02/09/2015

Re: None

Friday, 02/19/2016 6:31:20 PM

Friday, February 19, 2016 6:31:20 PM

Post# of 403159
K paper preview: ah, let's see. For those who are actually waiting for such a paper-

We gave slowly escalating doses of a very short half life novel anti cancer drug to 4 dozen patients with endstage solid tumors. At these doses Kevetrin was safe.

We hope to report on efficacy in phase 2/3 studies, and we are in the process of starting these trials for ovarian cancer and pancreatic cancer.

That covers it folks
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News